LXRX - Lexicon Pharmaceuticals Inc

https://www.lexpharma.com

Momentum: Bearish

Recent News

Lexicon Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 6, 2025

THE WOODLANDS, Texas, July 23, 2025 ( GLOBE NEWSWIRE ) -- Lexicon Pharmaceuticals, Inc. ( Nasdaq: LXRX ) today announced the Company will release its second quarter 2025 financial results on Wednesday, August 6, 2025, prior to market open. Management will conduct a conference call and live ...

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development and commercialization of pharmaceutical products. The company is headquartered in The Woodlands, Texas.

52W High

$2.18

52W Low

$0.28

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

1.27

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

-2.58

EV/Revenue (<3 favorable)

5.38

P/S (TTM) (<3 favorable)

6.78

P/B (<3 favorable)

3.06

Ownership

Balanced

Source: Overview

Insiders (1–5% typical)

1.17%

Institutions (25–75% balanced)

72.07%

Shares Outstanding

363,399,000

Float

183,891,000

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

58,432,000

Gross Profit (TTM)

-25,351,000

EPS (TTM)

-0.32

Profit Margin (>10% good)

-2.06%

Operating Margin (TTM) (higher better)

0.13%

ROE (TTM) (>15% strong)

-0.65%

EPS YoY (Quarterly) (>10% good)

-0.63

Revenue YoY (Quarterly) (>8% good)

16.53

Momentum

Bearish momentum

Value

0.0019

-0.0031

Trend

Rising

Signal Cross

Crossed Up Today

As of

Sep. 12, 2025